Close Menu

NEW YORK (GenomeWeb) – Two letters to the editor of the New England Journal of Medicine have pointed out possible flaws or omissions in a recent paper that suggested that a gene test could guide breast cancer treatment decisions.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.